Alexandria Real Estate Equities
ARE
#2522
Rank
โ‚น681.57 B
Marketcap
โ‚น3,911
Share price
-0.60%
Change (1 day)
-35.70%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2025 (TTM): -โ‚น89.1 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are โ‚น2.94 Billion. a decrease over its 2024 earnings that were of โ‚น66.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2025

Annual earnings

Year Earnings Change
2025 -โ‚น94.12 Billion-242.13%
2024 โ‚น66.22 B96.11%
2023 โ‚น33.76 B-53.56%
2022 โ‚น72.71 B-3.96%
2021 โ‚น75.71 B-20.26%
2020 โ‚น94.95 B72.88%
2019 โ‚น54.92 B3.11%
2018 โ‚น53.26 B73.54%
2017 โ‚น30.69 B464.88%
2016 โ‚น5.43 B-77.32%
2015 โ‚น23.95 B36.31%
2014 โ‚น17.57 B-10.81%
2013 โ‚น19.70 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น968.92 B-1,129.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.446 T-2,699.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น853.32 B-1,006.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น931.37 B-1,089.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น112.74 B-219.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น886.78 B-1,042.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น54.73 B-158.16%๐Ÿ‡บ๐Ÿ‡ธ USA